Founded in 1992, Bluebird bio (formerly Genetix Pharmaceuticals Inc.) is developing innovative gene therapies for severe genetic disorders. At the heart of bluebird bio’s product creation efforts is its broadly applicable gene therapy platform for the development of novel treatments for diseases with few or no clinical options.